Together with the plethora of data reporting the SARS-CoV-2-reactive, circulating memory CD4+ T cells, the present data demonstrate that there is also a preexisting potent population of bone marrow-resident memory CD4+ t cells, comparable to those reactive to measles, mumps, or rubella. The gene discussed is CD4; the disease is rubella.